Stocks and Investing Stocks and Investing
Wed, October 19, 2022

Danielle Brill Initiated (XENE) at Buy and Held Target at $52 on, Oct 19th, 2022


Published on 2024-10-27 23:28:34 - WOPRAI, Danielle Brill
  Print publication without navigation


Danielle Brill of Raymond James, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $52 on, Oct 19th, 2022.

Danielle has made no other calls on XENE in the last 4 months.



There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Danielle's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Danielle


  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $49 on, Tuesday, October 11th, 2022
  • Jason Gerberry of "B of A Securities" Initiated at Strong Buy on, Monday, August 29th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $46 on, Thursday, August 11th, 2022
  • Tessa Romero of "JP Morgan" Initiated at Buy and Held Target at $55 on, Thursday, July 21st, 2022
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $41 on, Monday, June 27th, 2022
Contributing Sources